Opendata, web and dolomites
H2020 projects about "antigens"
The page lists 109 projects related to the topic "antigens".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | DiViNe | Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | 2015 |
| 3 | PredicTOOL | Nanomethods to understand what makes an endogenous protein immunogenic | 2015 |
| 4 | Crosstag | Unravelling cross-presentation pathways using a chemical biology approach | 2015 |
| 5 | Rethyming | Rebuilding the human thymus to create a tolerising system for allogeneic tissue and organ transplantation | 2015 |
| 6 | SOS | Sorting of Self | 2015 |
| 7 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 8 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 9 | Vaccinesurvey | Monitor population immunity against vaccine preventable diseases | 2015 |
| 10 | DCmucoHIV | HIV/SIV exploits DCs in mucosal infection: mechanisms of transmission and modulation by semen associated factors | 2015 |
| 11 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 12 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 13 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 14 | TEC_Pro | Molecular control of self-renewal and lineage specification in thymic epithelial cell progenitors in vivo. | 2015 |
| 15 | TIPPDECRA | Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis | 2016 |
| 16 | BCELLMECHANICS | Regulation of antibody responses by B cell mechanical activity | 2015 |
| 17 | GlyCoCan | Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics | 2015 |
| 18 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 19 | Colodetect | Development of a novel blood-based diagnostic test for colorectal cancer | 2015 |
| 20 | MYCOCHASSIS | Engineering of a minimal bacterial therapeutic chassis | 2015 |
| 21 | MARA | Molecular Analytical Robotics Assays | 2015 |
| 22 | VADEMA | Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry | 2016 |
| 23 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 24 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 25 | LIPID IMMUNITY | Regulation of lipid-mediated immunity in the intestine | 2016 |
| 26 | HONEYDIAB-8 | Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes | 2016 |
| 27 | MAIT | Evolutionary conserved T cells specific for a microbial metabolite: deciphering their development in the thymus and mapping their interactions with the gut microbiota in vivo. | 2016 |
| 28 | ADHERE | Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy | 2016 |
| 29 | SugarBlock | Unraveling the protein glycosylation of Plasmodium falciparum is crucial for development of novel therapeutics against malaria | 2016 |
| 30 | SAP-Nano | A disruptive technology for vaccines manufacturing based on Self-Assembled Polymeric Nanoparticulate systems | 2016 |
| 31 | FAT NKT | Targeting iNKT cell and adipocyte crosstalk for control of metabolism and body weight | 2016 |
| 32 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 33 | MultiViVax | Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria | 2017 |
| 34 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 35 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 36 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
| 37 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 38 | NMR4Nanos | Development and application of NMR-based tools to inorganic nanocarriers for effective vaccine delivery | 2017 |
| 39 | 3D_Tryps | The role of three-dimensional genome architecture in antigenic variation | 2017 |
| 40 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 41 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 42 | CriTiClean | Supercritical carbon dioxide for delipidation of soft tissue - Suppressing transplant rejection. | 2017 |
| 43 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 44 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 45 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 46 | BCRdangerCOMPETITION | The role of danger signal and cellular competition in the elimination of B cells lacking the B cell receptor. | 2017 |
| 47 | Hepatocarcinoma IVM | Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | 2017 |
| 48 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 49 | ThymusTolerance | Delineation of molecular mechanisms underlying the establishment and breakdown of immunological tolerance in the thymus | 2017 |
| 50 | PIGSs | Program for Innovative Global Prevention of Streptococcus suis. | 2017 |
| 51 | gdTCR-Ligand | Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy | 2017 |
| 52 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 53 | ALLERGUT | Mucosal Tolerance and Allergic Predisposition: Does it all start in the gut? | 2017 |
| 54 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 55 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 56 | BioNanoPattern | Protein nano-patterning using DNA nanotechnology; control of surface-based immune system activation | 2018 |
| 57 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 58 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 59 | BEAT | regulation of B-cell Epitope migration and Autoimmunity by T follicular helper cells | 2018 |
| 60 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
| 61 | MTBHLAE | Investigation of a novel immune cell type in Tuberculosis: characterization of the specificity, function and pathogen killing ability of T cells restricted by non-classical HLA-E molecules | 2018 |
| 62 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 63 | Striking streaks | Invariant Natural Killer T-cells in atherogenesis | 2018 |
| 64 | MAGIC | Magnification of Asthma by human memory Group 2 Innate lymphoid Cells | 2018 |
| 65 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 66 | TakeupSLaCk | Role and regulation of dendritic cell functions by Solute Carrier Transporters | 2019 |
| 67 | IMMUNEDIVERSITY | Defining of human adaptive immune gene diversity and its impact on disease | 2018 |
| 68 | RAPID | RNA particles for Preparedness against Infectious Diseases | 2018 |
| 69 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 70 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 71 | FunDiT | Functional Diversity of T cells | 2019 |
| 72 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 73 | MycoVAP | Bacterial chassis for treating ventilator-associated pneumonia (VAP) | 2019 |
| 74 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
| 75 | TopSpec | Next generation precision antibody profiling - from science fiction to reality | 2019 |
| 76 | DCRIDDLE | A novel physiological role for IRE1 and RIDD..., maintaining the balance between tolerance and immunity? | 2019 |
| 77 | LymphMap | Navigating lymphatic formation and function in health and disease | 2019 |
| 78 | SUPRAVACC | Supramolecular engineering of glycan-decorated peptides as synthetic vaccines | 2019 |
| 79 | RoBE | Study of the role of BANK1 in antibody production and antibody-independent functions of B cells in SLE | 2019 |
| 80 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
| 81 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 82 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 83 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 84 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
| 85 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 86 | Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | 2019 |
| 87 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 88 | PI3K-in-tolerance | PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance | 2019 |
| 89 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 90 | Malaria POC | Ultrasensitive detection of transmissible malaria | 2019 |
| 91 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 92 | PeptiCHIP | PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy | 2019 |
| 93 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 94 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
| 95 | B-DOMINANCE | B Cell Immunodominance in Antiviral Immunity | 2019 |
| 96 | VIVA | Vaccine development against variable pathogens | 2020 |
| 97 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 98 | TrojanDC | TrojanDC | 2019 |
| 99 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 100 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 101 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
| 102 | nbPTMs | A multifaceted platform for exploring nucleotide-based post-translational modifications | 2021 |
| 103 | MultiSeroSurv | Algorithms and multiplex assays for integrated serological surveillance of malaria and neglected tropical diseases | 2020 |
| 104 | POST-IT | Pathogen Oriented SNARE Trafficking for Immune Tailoring | 2020 |
| 105 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 106 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 107 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 108 | QS21-Mech | Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) | 2020 |
| 109 | VacTrack | Dissecting the protection mechanism of new generation vaccines by synchronizing systems biology with in vivo imaging | 2021 |